GLP-1 drug claims rose from 6.9% of employer plans in 2023 to 10.5% in 2025, according to Blue Cross Blue Shield data
The K d for the reaction between RT and GSH is 3.7 mM
An invited review in the New England Journal of Medicine stated it plainly: the positive cardiac and renal effects of GLP-1 receptor agonists are more than just improvement in ambient glucose concentrations, pointing to pleiotropic vascular actions as key contributors to the MACE reductions observed across LEADER, SUSTAIN-6, SELECT, and the other landmark trials
Simionescu BC, Drobota M, Timpu D, Vasiliu T, Constantinescu CA, Rebleanu D
In the past year, many telehealth and digital health companies, including Hims & Hers competitor Ro, have jumped into the market, offering prescriptions for GLP-1s as part of an existing weight loss or chronic condition management program, or creating a new service line targeting obesity care
A strong jet of water striking the lyophilizate directly can mechanically damage (denature) the peptide structure